| Name | Title | Contact Details |
|---|
Alturas Analytics is a Moscow, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Northeast Dental is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Smoky Lake - Family and Community Support Services is a Smoky Lake, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mercyhealth is a regional health system with over 700 employed physician partners, seven hospitals and 85 primary and specialty care locations throughout 50 northern Illinois and southern Wisconsin communities. We are committed to being a top integrated health care provider and continuously work to make life better for the people, families and communities we serve. As an integrated health care provider, we provide exceptional, coordinated health care that spans four core service divisions: hospital-based services, clinic-based services, post-acute care and retail services, and a wholly owned insurance company. These four core service divisions make up our comprehensive, vertically integrated delivery system, and integrated delivery is what makes Mercyhealth unique in serving the full range of health care needs for our patients. Every day, our 8,000+ employee take to heart our passion for making lives better. Our providers, nurses and partners are committed to working together to make lives better for our patients and their families. Touching lives invigorates, inspires and drives us to do our very best, and we continuously look for ways to make each life better with the utmost care and professionalism. This can be as complex as a cutting-edge procedure or as simple as a smile. Nothing is ever too small or taken for granted. Everything matters. And we never miss a beat.
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.